Correction: Preclinical development of 1B7/CD3, a novel anti-TSLPR bispecific antibody that targets CRLF2-rearranged Ph-like B-ALL (Leukemia, (2023), 37, 10, (2006-2016), 10.1038/s41375-023-02010-y)

Ze Tian; Chunhua Shi; Guojun Yang; Jason K. Allen; Qing Shi; Amin AL-Shami; Jill Wardell Olson; Melinda G. Smith; Qing Chang; Jasbir Kaur; Junping You; Timothy E. Lofton; Michelle A. Gonzalez; Qi Zhang; Dong Xing Zha; Sarah K. Tasian; Nitin Jain; Marina Y. Konopleva; Timothy Heffernan; Jeffrey J. Molldrem

doi:10.1038/s41375-023-02090-w

Correction: Preclinical development of 1B7/CD3, a novel anti-TSLPR bispecific antibody that targets CRLF2-rearranged Ph-like B-ALL (Leukemia, (2023), 37, 10, (2006-2016), 10.1038/s41375-023-02010-y)

Ze Tian, Chunhua Shi, Guojun Yang, Jason K. Allen, Qing Shi, Amin AL-Shami, Jill Wardell Olson, Melinda G. Smith, Qing Chang, Jasbir Kaur, Junping You, Timothy E. Lofton, Michelle A. Gonzalez, Qi Zhang, Dong Xing Zha, Sarah K. Tasian, Nitin Jain, Marina Y. Konopleva, Timothy Heffernan, Jeffrey J. Molldrem

Research output: Contribution to journal › Comment/debate › peer-review

Abstract

In this article the author’s name Amin AL-Shami was incorrectly written as Amin AI-Shami. The original article has been corrected.

Original language	English (US)
Journal	Leukemia
DOIs	https://doi.org/10.1038/s41375-023-02090-w
State	Accepted/In press - 2023

ASJC Scopus subject areas

Hematology
Oncology
Cancer Research

Access to Document

10.1038/s41375-023-02090-w

Cite this

Tian, Z., Shi, C., Yang, G., Allen, J. K., Shi, Q., AL-Shami, A., Olson, J. W., Smith, M. G., Chang, Q., Kaur, J., You, J., Lofton, T. E., Gonzalez, M. A., Zhang, Q., Zha, D. X., Tasian, S. K., Jain, N., Konopleva, M. Y., Heffernan, T., & Molldrem, J. J. (Accepted/In press). Correction: Preclinical development of 1B7/CD3, a novel anti-TSLPR bispecific antibody that targets CRLF2-rearranged Ph-like B-ALL (Leukemia, (2023), 37, 10, (2006-2016), 10.1038/s41375-023-02010-y). Leukemia. https://doi.org/10.1038/s41375-023-02090-w

Tian, Z, Shi, C, Yang, G, Allen, JK, Shi, Q, AL-Shami, A, Olson, JW, Smith, MG, Chang, Q, Kaur, J, You, J, Lofton, TE, Gonzalez, MA, Zhang, Q, Zha, DX, Tasian, SK, Jain, N, Konopleva, MY, Heffernan, T & Molldrem, JJ 2023, 'Correction: Preclinical development of 1B7/CD3, a novel anti-TSLPR bispecific antibody that targets CRLF2-rearranged Ph-like B-ALL (Leukemia, (2023), 37, 10, (2006-2016), 10.1038/s41375-023-02010-y)', Leukemia. https://doi.org/10.1038/s41375-023-02090-w

@article{bf52e4211af04eef9d83f3bd3a19a242,

title = "Correction: Preclinical development of 1B7/CD3, a novel anti-TSLPR bispecific antibody that targets CRLF2-rearranged Ph-like B-ALL (Leukemia, (2023), 37, 10, (2006-2016), 10.1038/s41375-023-02010-y)",

abstract = "In this article the author{\textquoteright}s name Amin AL-Shami was incorrectly written as Amin AI-Shami. The original article has been corrected.",

author = "Ze Tian and Chunhua Shi and Guojun Yang and Allen, {Jason K.} and Qing Shi and Amin AL-Shami and Olson, {Jill Wardell} and Smith, {Melinda G.} and Qing Chang and Jasbir Kaur and Junping You and Lofton, {Timothy E.} and Gonzalez, {Michelle A.} and Qi Zhang and Zha, {Dong Xing} and Tasian, {Sarah K.} and Nitin Jain and Konopleva, {Marina Y.} and Timothy Heffernan and Molldrem, {Jeffrey J.}",

note = "Publisher Copyright: {\textcopyright} 2023, The Author(s).",

year = "2023",

doi = "10.1038/s41375-023-02090-w",

language = "English (US)",

journal = "Leukemia",

issn = "0887-6924",

publisher = "Nature Publishing Group",

}

TY - JOUR

T1 - Correction

T2 - Preclinical development of 1B7/CD3, a novel anti-TSLPR bispecific antibody that targets CRLF2-rearranged Ph-like B-ALL (Leukemia, (2023), 37, 10, (2006-2016), 10.1038/s41375-023-02010-y)

AU - Tian, Ze

AU - Shi, Chunhua

AU - Yang, Guojun

AU - Allen, Jason K.

AU - Shi, Qing

AU - AL-Shami, Amin

AU - Olson, Jill Wardell

AU - Smith, Melinda G.

AU - Chang, Qing

AU - Kaur, Jasbir

AU - You, Junping

AU - Lofton, Timothy E.

AU - Gonzalez, Michelle A.

AU - Zhang, Qi

AU - Zha, Dong Xing

AU - Tasian, Sarah K.

AU - Jain, Nitin

AU - Konopleva, Marina Y.

AU - Heffernan, Timothy

AU - Molldrem, Jeffrey J.

PY - 2023

Y1 - 2023

N2 - In this article the author’s name Amin AL-Shami was incorrectly written as Amin AI-Shami. The original article has been corrected.

AB - In this article the author’s name Amin AL-Shami was incorrectly written as Amin AI-Shami. The original article has been corrected.

UR - http://www.scopus.com/inward/record.url?scp=85178230031&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85178230031&partnerID=8YFLogxK

U2 - 10.1038/s41375-023-02090-w

DO - 10.1038/s41375-023-02090-w

M3 - Comment/debate

C2 - 38036631

AN - SCOPUS:85178230031

SN - 0887-6924

JO - Leukemia

JF - Leukemia

ER -

Correction: Preclinical development of 1B7/CD3, a novel anti-TSLPR bispecific antibody that targets CRLF2-rearranged Ph-like B-ALL (Leukemia, (2023), 37, 10, (2006-2016), 10.1038/s41375-023-02010-y)

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this